Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Acute cholecystitis is a common inflammatory condition of the gallbladder, primarily caused by gallstone obstruction, leading to increased intraluminal pressure, ischemia, and infection. While laparoscopic cholecystectomy remains the standard treatment, gallbladder drainage techniques have emerged as effective alternatives for high-risk surgical patients. This review explores the indications, techniques, and comparative outcomes of various gallbladder drainage methods, including percutaneous transhepatic gallbladder drainage (PTGBD), endoscopic transpapillary gallbladder drainage (ETGBD), and endoscopic ultrasound-guided gallbladder drainage (EUS-GBD). Endoscopic ultrasound-guided transmural gallbladder drainage, particularly with lumen-apposing metal stents (LAMS), has shown high clinical success rates with fewer complications compared to traditional methods. Advances in stent technology and procedural techniques continue to improve patient outcomes. However, further research is needed to establish long-term efficacy and determine optimal patient selection criteria for different drainage methods. The review highlights the evolving landscape of gallbladder drainage and the need for standardized guidelines to optimize treatment strategies for high-risk patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333829PMC
http://dx.doi.org/10.1097/MS9.0000000000003527DOI Listing

Publication Analysis

Top Keywords

gallbladder drainage
28
drainage
9
acute cholecystitis
8
gallbladder
8
drainage methods
8
endoscopic ultrasound-guided
8
percutaneous transpapillary
4
transpapillary transmural
4
transmural drainage
4
drainage acute
4

Similar Publications

Introduction: Laparoscopic cholecystectomy (LC) is the gold standard for gallbladder pathologies, but carries risks of bile duct injury (BDI) and vascular complications, such as hepatic artery pseudoaneurysm (HAP). While BDI occurs in 0.3-0.

View Article and Find Full Text PDF

The therapeutic value of "Bile Transfer" for complications of acute pancreatitis: A retrospective clinical study.

J Adv Res

August 2025

Department of Oncology and Laparoscopy Surgery, The First Affiliated Hospital of Harbin Medical University, 150000 Harbin, Heilongjiang Province, China; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, 150000 Harbin, Heilongj

Introduction: Acute pancreatitis (AP) is one of the most common gastrointestinal diseases, imposing a significant burden on patients, with its incidence steadily increasing worldwide. Despite a drop in fatality rates, AP-related complications remain high, impacting prognosis.

Objectives: This retrospective clinical study introduces the concept of "bile transfer" (BT) and explores its potential in reducing AP-related complications.

View Article and Find Full Text PDF

: The TOPAZ-1 phase III trial reported a survival benefit of using durvalumab, an anti-programmed death ligand 1 (anti-PD-L1) antibody, in combination with gemcitabine and cisplatin (GCD) treatment in patients with advanced biliary tract cancer. This retrospective study investigated the efficacy and safety of GCD treatment for advanced biliary tract cancer in real-world conditions. : The study subjects were 52 patients with biliary tract cancer who received GCD therapy between January 2023 and May 2024.

View Article and Find Full Text PDF